» Articles » PMID: 37307904

Approach to Non-type 2 Asthma

Overview
Journal Respir Med
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2023 Jun 12
PMID 37307904
Authors
Affiliations
Soon will be listed here.
Citing Articles

Advances in Biologic Therapies for Allergic Diseases: Current Trends, Emerging Agents, and Future Perspectives.

Alska E, Laszczych D, Napiorkowska-Baran K, Szymczak B, Rajewska A, Rubisz A J Clin Med. 2025; 14(4).

PMID: 40004611 PMC: 11856668. DOI: 10.3390/jcm14041079.


Asthma Biologics Across the T2 Spectrum of Inflammation in Severe Asthma: Biomarkers and Mechanism of Action.

Lindsley A, Lugogo N, Reeh K, Spahn J, Parnes J J Asthma Allergy. 2025; 18():33-57.

PMID: 39830595 PMC: 11742565. DOI: 10.2147/JAA.S496630.


Functional characterization of OR51B5 and OR1G1 in human lung epithelial cells as potential drug targets for non-type 2 lung diseases.

Awad N, Weidinger D, Greune L, Kronsbein J, Heinen N, Westhoven S Cell Biol Toxicol. 2024; 40(1):96.

PMID: 39538061 PMC: 11561009. DOI: 10.1007/s10565-024-09935-9.


Revisiting Asthma Obstructive Sleep Apnea Overlap: Current Knowledge and Future Needs.

Saxena D, Imayama I, Adrish M J Clin Med. 2023; 12(20).

PMID: 37892689 PMC: 10607310. DOI: 10.3390/jcm12206552.